197 related articles for article (PubMed ID: 16416793)
21. Genetic testing for cancer susceptibility.
Calzone KA; Soballe PW
Surg Clin North Am; 2008 Aug; 88(4):705-21, v. PubMed ID: 18672137
[TBL] [Abstract][Full Text] [Related]
22. Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Domchek SM; Bradbury A; Garber JE; Offit K; Robson ME
J Clin Oncol; 2013 Apr; 31(10):1267-70. PubMed ID: 23460708
[No Abstract] [Full Text] [Related]
23. Challenges for the implementation of routine molecular diagnostics in cancer care.
de Castro DG
Expert Rev Mol Diagn; 2011 Jul; 11(6):549-51. PubMed ID: 21745007
[No Abstract] [Full Text] [Related]
24. Testing for cancer susceptibility genes in children.
Laxova R
Adv Pediatr; 1999; 46():1-40. PubMed ID: 10645460
[TBL] [Abstract][Full Text] [Related]
25. Legislation on genetic testing and the practice of oncology.
Surbone A
Crit Rev Oncol Hematol; 2009 Feb; 69(2):95-7. PubMed ID: 18993081
[No Abstract] [Full Text] [Related]
26. DNA testing for cancer predisposition.
Loescher LJ
Oncol Nurs Forum; 1998 Sep; 25(8):1317-27. PubMed ID: 9766286
[TBL] [Abstract][Full Text] [Related]
27. [DNA-based diagnosis of hereditary tumour predisposition].
Menko FH; Ligtenberg MJ; Brouwer T; Hahn DE; Ausems MG
Ned Tijdschr Geneeskd; 2007 Feb; 151(5):295-8. PubMed ID: 17326472
[TBL] [Abstract][Full Text] [Related]
28. The genetics of HNPCC: application to diagnosis and screening.
Abdel-Rahman WM; Mecklin JP; Peltomäki P
Crit Rev Oncol Hematol; 2006 Jun; 58(3):208-20. PubMed ID: 16434208
[TBL] [Abstract][Full Text] [Related]
29. [Study of bladder cancer gene and relevant molecular biology should be strengthened].
Li CL; Han SJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):793-4. PubMed ID: 17565855
[No Abstract] [Full Text] [Related]
30. Genetic testing in neuromuscular disease.
Krajewski KM; Shy ME
Neurol Clin; 2004 Aug; 22(3):481-508, v. PubMed ID: 15207873
[TBL] [Abstract][Full Text] [Related]
31. Differential gene expression in patients genetically predisposed to pancreatic cancer.
Zervos EE; Tanner SM; Osborne DA; Bloomston M; Rosemurgy AS; Ellison EC; Melvin WS; de la Chapelle A
J Surg Res; 2006 Oct; 135(2):317-22. PubMed ID: 16815451
[TBL] [Abstract][Full Text] [Related]
32. [Molecular markers having a prognostic or therapeutic value in cancer].
Brousset P
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S69-70. PubMed ID: 18984307
[No Abstract] [Full Text] [Related]
33. [BRCA1: from the gene identification to the cancer risk estimation].
Stoppa-Lyonnet D; Jeanpierre M
Med Sci (Paris); 2004 Mar; 20(3):262-3. PubMed ID: 15067565
[No Abstract] [Full Text] [Related]
34. Molecular genetic testing for inherited disorders.
Pagon RA
Expert Rev Mol Diagn; 2004 Mar; 4(2):135-40. PubMed ID: 14995901
[TBL] [Abstract][Full Text] [Related]
35. [Genetic testing for familial cancer in clinical practice].
Hibi Y
Nihon Geka Gakkai Zasshi; 2014 Jan; 115(1):33. PubMed ID: 24597335
[No Abstract] [Full Text] [Related]
36. Genetic counseling and genetic testing in ophthalmology.
Sutherland JE; Day MA
Curr Opin Ophthalmol; 2009 Sep; 20(5):343-50. PubMed ID: 19620864
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility.
Gao L; Nieters A; Brenner H
Aliment Pharmacol Ther; 2008 Sep; 28(5):565-73. PubMed ID: 18544073
[TBL] [Abstract][Full Text] [Related]
38. [Cancer genetic predisposition: current events and perspectives in 2010].
Stoppa-Lyonnet D; Stern MH; Soufir N; Lenoir G
Pathol Biol (Paris); 2010 Oct; 58(5):324-30. PubMed ID: 20691548
[TBL] [Abstract][Full Text] [Related]
39. Hereditary cancer gene hunting. a phase of declining success?
Eisinger F; Horsman D
Med Hypotheses; 2007; 69(3):690-2. PubMed ID: 17363177
[TBL] [Abstract][Full Text] [Related]
40. [Genetic counseling].
Utsunomiya J; Minegishi M
Gan To Kagaku Ryoho; 2005 Jul; 32(7):967-72. PubMed ID: 16044957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
